ENVARSUS XR Trademark

Trademark Overview


On Thursday, October 16, 2014, a trademark application was filed for ENVARSUS XR with the United States Patent and Trademark Office. The USPTO has given the ENVARSUS XR trademark a serial number of 79165003. The federal status of this trademark filing is PARTIAL SECTION 71 ACCEPTED as of Thursday, September 11, 2025. This trademark is owned by Veloxis Pharmaceuticals A/S. The ENVARSUS XR trademark is filed in the Treatment & Processing of Materials Services, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

[ Treatment of materials, namely, milling, grinding, mixing, compressing, and melting of pharmaceutical, medicinal, bio technical and bacteriological substances, preparations, formulations and solutions, for use in the pharmaceutical and medical industries ]

Pharmaceutical preparations, namely, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplantation patients; medical preparations and drug delivery systems, pharmaceutical modified release systems, and controlled release systems, comprised of tablets, [ granules, ] pills [, sachets, powders, capsules, all of the above ] for use in the treatment of [ mental and physical disorders, traumas and emergencies, addictions, aging, allergy, ] immunology, [ burns, ] diseases of the heart and blood vessels, [ dental and gum diseases, skin diseases, nutritional and dietary diseases, ] diseases of the endocrinological system and pancreatic diseases, [ diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, ] neurological diseases, nephrological diseases, [ diseases in the obstetrical and gynaecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the...

[ Medical services; medical and pharmaceutical assistance and consultation, namely, medical and pharmaceutical information services, namely, providing medical and scientific research information in the field of pharmaceuticals ]

[ Scientific and technological services, namely, clinical testing and technology transfer services as well as research and design in connection therewith, namely, within the medical, pharmaceutical, bio technical and bacteriological areas and providing scientific consultation and information relating thereto; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; materials testing for the pharmaceutical and medical industries ]
envarsus xr

General Information


Serial Number79165003
Word MarkENVARSUS XR
Filing DateThursday, October 16, 2014
Status707 - PARTIAL SECTION 71 ACCEPTED
Status DateThursday, September 11, 2025
Registration Number4839039
Registration DateTuesday, October 27, 2015
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 11, 2015

Trademark Statements


Goods and Services[ Treatment of materials, namely, milling, grinding, mixing, compressing, and melting of pharmaceutical, medicinal, bio technical and bacteriological substances, preparations, formulations and solutions, for use in the pharmaceutical and medical industries ]
Description of MarkThe mark consists of three curved horizontal bands above the wording "ENVARSUS XR".
Goods and ServicesPharmaceutical preparations, namely, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplantation patients; medical preparations and drug delivery systems, pharmaceutical modified release systems, and controlled release systems, comprised of tablets, [ granules, ] pills [, sachets, powders, capsules, all of the above ] for use in the treatment of [ mental and physical disorders, traumas and emergencies, addictions, aging, allergy, ] immunology, [ burns, ] diseases of the heart and blood vessels, [ dental and gum diseases, skin diseases, nutritional and dietary diseases, ] diseases of the endocrinological system and pancreatic diseases, [ diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, ] neurological diseases, nephrological diseases, [ diseases in the obstetrical and gynaecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and threat, diseases and afflictions in the psychiatric field, ] pulmonological diseases [ and afflictions, rheumatism, urological diseases and afflictions and generalized pain ]
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Services[ Medical services; medical and pharmaceutical assistance and consultation, namely, medical and pharmaceutical information services, namely, providing medical and scientific research information in the field of pharmaceuticals ]
NOT AVAILABLE"XR"
Goods and Services[ Scientific and technological services, namely, clinical testing and technology transfer services as well as research and design in connection therewith, namely, within the medical, pharmaceutical, bio technical and bacteriological areas and providing scientific consultation and information relating thereto; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; materials testing for the pharmaceutical and medical industries ]

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status CodeG - NOT AVAILABLE
Class Status DateThursday, September 11, 2025
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeG - NOT AVAILABLE
Class Status DateThursday, September 11, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeG - NOT AVAILABLE
Class Status DateThursday, September 11, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVeloxis Pharmaceuticals, Inc.
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressUS

Party NameVeloxis Pharmaceuticals A/S
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDK

Party NameVeloxis Pharmaceuticals A/S
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDK-2970 Hørsholm
DK

Party NameVeloxis Pharmaceuticals A/S
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDK-2970 Hørsholm
DK

Trademark Events


Event DateEvent Description
Tuesday, May 19, 2015APPLICATION FILING RECEIPT MAILED
Saturday, May 23, 2015NON-FINAL ACTION WRITTEN
Sunday, May 24, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, May 26, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 13, 2015REFUSAL PROCESSED BY IB
Thursday, May 14, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 15, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 15, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Saturday, May 16, 2015ASSIGNED TO EXAMINER
Tuesday, May 26, 2015REFUSAL PROCESSED BY MPU
Friday, June 26, 2015CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, July 2, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 2, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 22, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 5, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 5, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, August 11, 2015PUBLISHED FOR OPPOSITION
Tuesday, August 11, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 17, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 24, 2015ASSIGNED TO LIE
Tuesday, July 7, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 8, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 21, 2015NOTIFICATION PROCESSED BY IB
Tuesday, October 27, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, January 27, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, May 19, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 21, 2015CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, September 1, 2015CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Thursday, May 19, 2016FINAL DISPOSITION PROCESSED
Thursday, September 15, 2016NEW REPRESENTATIVE AT IB RECEIVED
Friday, September 21, 2018CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Friday, May 21, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, October 26, 2021TEAS SECTION 71 & 15 RECEIVED
Friday, July 15, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, January 18, 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, August 3, 2018CORRECTION TRANSACTION RECEIVED FROM IB
Friday, February 7, 2020NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, October 27, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, September 18, 2021CHANGE OF OWNER RECEIVED FROM IB
Monday, May 23, 2022CANCELLED SECTION 71
Wednesday, May 25, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 17, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 22, 2021OFFICE ACTION ISSUED POU1
Monday, March 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 17, 2022TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, May 24, 2022NOTICE OF CANCELLATION SEC. 71 E-MAILED
Wednesday, May 25, 2022REINSTATED
Monday, October 28, 2024COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Wednesday, May 25, 2022REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Wednesday, May 25, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 25, 2022NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Tuesday, March 21, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 21, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 21, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 21, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 21, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 17, 2024INTERNATIONAL REGISTRATION RENEWED
Monday, September 8, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 11, 2025REGISTERED - PARTIAL SEC 71 ACCEPTED
Thursday, September 11, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Friday, November 8, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, May 30, 2025TEAS SECTION 71 RECEIVED